The metabolic and functional alterations which occur during the acute phase of nephrotoxic nephritis (NTN) in rats, a model of immune-mediated glomerulonephritis, result from a cooperative interaction between PMNs and platelets (PLTs). In consequence, we hypothesized that fibrinogen (Fg) might play a critical role in this process and, accordingly, we found that defibrination of animals decreased both the acute phase proteinuria in NTN (-70%) as well as the influx of PLTs and PMNs into the glomerulus (-40-50%). Invest. 1994. 94:928-936.)
Introduction
Nephrotoxic nephritis (NTN)1 in rats serves as a model system for immune-mediated glomerulonephritis in man (1, 2) . Studies 1. Abbreviations used in this paper: CD45, leukocyte common antigen; Fg, fibrinogen; HRP, horseradish peroxidase; NTN, nephrotoxic nephritis; PLT, platelet. into the pathogenesis of this disease model show that leukocytes are critical effectors of the glomerular damage and dysfunction in this disease model and the accompanying alterations in glomerular biochemistry (1, 2) . Because of the central role played by leukocytes in this form of experimental glomerulonephritis, the mechanisms by which these cells enter glomeruli in the context of inflammation, become activated, and induce glomerular dysfunction are of topical concern.
With respect to PMNs (which mediate the acute phase of NTN) it has become clear that their emigration into glomeruli is a complex function of the activation of complement, the production of local cytokines, the upregulation of vascular adhesion molecules, and the expression of /2 integrins on the PMNs (3) (4) (5) . In addition, in recent work by our laboratory, it appears that platelets (PLTs), as well, are essential for the efficient influx of PMNs into the glomerulus and contribute to the acute glomerular injury (6) . Specifically, we have found that PLTs are essential for the influx of PMNs into the glomerulus, the upregulation in glomerular leukotriene B4 production, and the evolution of proteinuria (6) . Conversely, PMNs are essential for the influx of PLTs into the glomerulus as well as the upregulation in glomerular thromboxane production (6) and are clearly a major effector for producing proteinuria (7) .
PLT-PMN interactions appear to be a common part of the acute inflammatory response and may be mediated via a myriad of different molecular mechanisms (8, 9) . In an effort to broach this general issue in the context of NTN, we focused specifically on fibrinogen (Fg). We hypothesized that Fg would play a critical role in the interaction of PLTs and PMNs in inflamed glomeruli based on prior in vivo data suggesting that defibrination/ fibrinolysis could ameliorate experimental glomerulonephritis (although not invariably) (10, 11) and on in vitro evidence that Fg could serve to activate PLTs and PMNs as well as play a role in their migration via effects on adherence and chemotaxis (12, 13) . Underscoring the potentially important role of Fg in inflammation are data which show that Fg alone (even in the absence of complement or immunoglobulin) is sufficient to render inert materials proinflammatory (14) .
By comparing and contrasting defibrination with Fg receptor blockade in vivo, by probing for /3 integrin expression in vivo using immunocytochemical techniques, and by examining PLT Monoclonal antibody to f3 integrin was raised and characterized as previously described (Fl 1) (15) . Rabbit anti-rat PLT polyclonal antiserum was raised and characterized also as described previously (6) . For visualizing the PLTs in glomerular cell preparations, this antibody was purified using protein A-Sepharose (Pharmacia LKB Biotechnology, Uppsala, Sweden) and directly labeled with HRP using a kit from Zymed Laboratories, Inc. (South San Francisco, CA).
Induction ofNTN and its pharmacologic/immunologic manipulation. The preparation of nephrotoxic serum has been detailed previously (6) . This antiserum contains no detectable endotoxin (< 0.1 U/ml). To induce nephritis, rats were given 5 ml/kg intravenously (i.v.). Urine was collected using a metabolic cage, and proteinuria was measured by the Bradford assay (Bio-Rad Laboratories). Glomeruli and renal tissue were harvested 3 or 24 h after disease induction for the analyses below. Glomeruli were harvested from kidneys perfused free of blood.
Various pharmacologic/immunologic manipulations were performed as follows: to defibrinate animals, Ancrod 50 U/kg was injected subcutaneously thrice daily for 5 d before disease induction. Prolonged treatment with Ancrod is necessary to deplete the internal pool of Fg within PLTs (16) . PLT depletion was induced before induction of disease by the injection of the aforementioned anti-PLT antiserum 10 ml/kg which decreases circulating PLT counts to undetectable levels but does not affect circulating leukocyte/PMN counts (reference 6 and data not shown). PMN depletion was generated by injection of anti-PMN antiserum 5 ml/kg. This protocol decreased circulating PMNs by > 90% but did not affect circulating PLT counts (data not shown).
To effect Fg receptor blockade, animals were given SC-49992, an RGD peptidomimetic (17, 18) . Although RGD peptides and their mimetics are not generally effective in inhibiting rat PLT aggregation in vitro, some RGD peptide analogues have been shown to prevent collageninduced thrombocytopenia in rats in vivo (19, 20) . We therefore used a potent mimetic of the RGDF tetrapeptide, SC49992, which has been demonstrated to inhibit human and dog PLT aggregation (17, 18) and to prevent collagen-induced thrombocytopenia in the rat (ED50 53 pg/kg).
We used a variant of the above protocol for induction of NTN because the short half-life of SC-49992 necessitated i.v. infusion. In these experiments, an intraarterial cannula was placed in the femoral artery under anesthesia to allow infusion of SC-49992. Animals were then allowed to recover, during which time they were infused with saline 2 ml/h to help maintain urine flow. After a 2-h period of equilibration, animals were injected with SC-49992 1 mg/kg or an equivalent amount of vehicle (saline) followed by nephrotoxic serum 5 ml/kg. For the next 3 h, animals were either given an infusion of SC-49992 80 jig/ kg per minute in saline or an equivalent volume of saline, at 2 ml/h, and urine was collected. At the end of 3 h, animals were killed as above to obtain glomeruli or tissue for the following analyses.
Glomerular isolation, cell dissociation, and immunostaining. Glomeruli were isolated from saline-perfused kidneys using a sieving protocol described previously which yields a preparation of glomeruli 80-90% pure (6) . The glomeruli were then dispersed into single cell preparations by a previously published enzymatic dissociation protocol (6) . This protocol yields a single cell suspension of mesangial cells and leukocytes. Occasional endothelial cells are present; however, epithelial cells are largely lost. Cell counts were performed after dissociation to obtain total cell yields and to assess viability (uniformly > 90% by trypan blue exclusion).
Glomerular leukocytes were quantified in these cell dissociates by immunocytochemistry. Aliquots of cell suspensions (-30,000 cells) were pelleted onto slides by cytocentrifuge (Shandon Inc., Pittsburgh, PA). The cells were fixed with methanol/acetone (50:50), and leukocytes were labeled with an anti-CD45 antibody as previously detailed (6) . Hematoxylin was used as a counterstain. The positive labeled cells were quantified as a percentage of the total by light microscopy and categorized by nuclear morphology as to lineage. Leukocyte counts per glomerulus were then calculated by multiplying leukocyte percentages (or subset fractions) by the total glomerular cell number. This technique correlates well with other methods of leukocyte quantification, such as in situ staining.
A similar protocol was used to assess the presence of PLTs in the glomerular cell dissociates using the aforementioned HRP-labeled anti-PLT polyclonal antibody as the detecting reagent (6) . PLTs were identified by positive staining as well as appropriate morphology.
For FACS® analysis, 1 X 106 glomerular cells were incubated with anti-rat CD45 or anti-rat [3 integrin monoclonal antibodies for 45 min in PBS with 10% goat serum at 40C, washed two times with PBS, and finally incubated with sheep anti-mouse IgG F(ab')-FITC for 45 min at 40C. Cells were again washed two times, and the samples were analyzed on a FACScan® (Becton Dickinson, Mountain View, CA).
Glomerular immunohistology. Glomerular depositions of rabbit IgG, rat C3, and rat Fg were determined by direct immunofluorescence on fresh frozen tissue using the aforementioned antibodies and previously published protocols (21) . Glomerular expression of CD45 or f3 integrin was visualized in fresh frozen tissue using the appropriate primary antibodies (see above, 1:100 dilution in PBS with 10% goat serum) along with an avidin-biotin-HRP kit from Vector Labs Inc. (Burlingame, CA). The secondary antibody in the kit was a biotinylated horse anti-mouse IgG. Staining used diaminobenzidine as the HRP substrate and hematoxylin as the counterstain. PLT-PMN interactions in vitro. PMNs were isolated by peritoneal lavage from rats injected with 7 ml of 1% glycogen intraperitoneally 4 h previously (preparations > 95% pure). PLTs were isolated from blood diluted 1:2 with heparinized saline by centrifugation at 800 g and washed with HBSS before use. Incubations for the respiratory burst were performed in a volume of 0.4 ml and contained PMNs (2 x 106) without or with PLTs (2 x 108). Cytochrome c (1 mg/ml) was included in the incubation as an indicator of superoxide production. Incubations were stimulated with either PMA (1 ,uM) or thrombin (3 U/ml) for 30 min at 37°C. In experiments to examine the role of Fg receptor blockade, SC-49992 (1 mg/ml) or anti-,f3 monoclonal antibody (10 og/ml) was preincubated with cells for 15 min at 37°C before stimulation. Superoxide production was measured by spectrophotometry (absorbance at 549 nm) and is expressed in relative units normalized for the agonist control (agonist stimulation = 100).
Statistical analysis. Statistical analysis was performed with the aid of STATA (Computing Resource Center, Los Angeles, CA). Values are expressed as mean+SEM. Each replicate represents the data from one animal. Two-way comparisons were made with a two-tailed Student's t test (unpaired or paired as appropriate). When comparisons were made between multiple groups, ANOVA was performed along with Bonferroni's correction for multiple comparisons. Significance levels are indicated in the text or figure legends.
Results
Defibrination and the evolution ofNTN. To begin to dissect out the role of Fg in the development of the inflammatory lesion of NTN, rats were defibrinated with Ancrod for a period of 5 d before disease induction to deplete both circulating levels of Fg as well as the reservoir of Fg within PLTs (16) . To evaluate the efficacy of defibrination, we examined the effect of this protocol on the intraglomerular deposition of Fg after induction of NTN. As expected, defibrination markedly attenuated the deposition of Fg in the glomerulus during the acute phase of nephritis, although there was no substantial effect on the deposition of either rabbit IgG (nephrotoxic serum) or C3 (Fig. 1) .
We concomitantly assessed the effect of Fg depletion on the proteinuria which accompanies NTN and which serves as an index of the invasion of inflammatory cells into the glomerulus and their activation (7) . Animals given nephrotoxic serum exhibited an approximately 10-fold elevation in urine protein over the 24 h after disease induction compared with normal controls (Fig. 2) Since a cooperative interaction between PLTs and PMNs is dissociates. As shown in Fig. 4 , dissociates from nephritic glocritical to the efficient influx of PMNs into the glomerulus (6), meruli contained substantial numbers of PLTs, singly or in we additionally quantified the PLT content of glomerular cell aggregates, both cell-associated and non-cell-associated. PLTs
Role of Fibrinogen in Glomerulonephritis associated with PMNs were also noted (Fig. 4, inset) . Defibrination moderately decreased the apparent numbers of PLTs: 18.0+0.5 vs 11.0+2.0 PLTs/100 cells in nephritic and defibrinated nephritic animals, respectively (n = 3, P = 0.07).
What was notable about these results taken together was the relative discrepancy between the decrease in total leukocyte and PLT influx with Fg depletion (- Fig. 5 ). However, in contrast to Fg depletion, SC49992 had little effect on either total leukocyte or PMN influx into glomeruli at 3 h (< 10% decrease, Fig. 5 ). We did observe a tendency towards a decline in PLT counts within glomerular cell dissociates with SC49992: 20.0+2.0 vs 13.0±2.0 PLTs/100 cells in nephritic and SC-49992-treated nephritic animals, respectively, though this was not statistically significant (n = 3, P = 0.18).
These data reinforced the impression that Fg was critical to the in situ activation of PLTs (Fig. 6 A) .
By 3 h after disease induction, however, expression of /3 integrins was dramatically increased in the glomerulus (Fig. 6 B) . Our However, in light of our previous results which show a cooperative interaction between PMNs and PLTs with respect to migration (6), we additionally addressed the effect of PMN depletion on /33 integrin expression within glomeruli. As shown in Fig. 7, A and B, PMN depletion markedly attenuated the influx of PMNs into the glomerulus as exhibited by staining for CD45. Moreover, PMN depletion, like PLT depletion, also completely prevented the increase in 63 integrin expression in acute NTN (Fig. 7, C and D performing FACS® on glomerular cell dissociates using our anti-/63 integrin monoclonal. As shown in Fig. 8 To understand in more specific terms how Fg might contribute to proteinuria, we examined PLT-PMN activation in vitro and the effect of Fg receptor blockade on this process. We focused on the PMN respiratory burst given prior studies implicating this process as a proximate cause of proteinuria in immunemediated glomerular injury (22) , and given data suggesting that Fg can mediate PLT-PMN coactivation in vitro (23, 24) .
PMNs incubated alone or with thrombin were quiescent in terms of the respiratory burst (Fig. 9 A) . When PLTs and PMNs were coincubated, a modest increase in the respiratory burst was noted (possibly in part resulting from PLT activation during isolation, Fig. 9 A) . However, when thrombin was added to PLT-PMN coincubations, a threefold increase in superoxide formation was seen (Fig. 9 A) . This stimulatory effect of thrombin in PLT-PMN coincubations was inhibited by 50% by Fg receptor blockade (Fig. 9 A) . Of interest, although Fg receptor blockade consistently inhibited PLT-PMN coactivation in terms of the respiratory burst, we noted that SC-49992 (but not anti-/63 antibody) inhibited the visually apparent heterologous aggregation.
PMA, in contrast to thrombin, directly stimulated the PMN respiratory burst (Fig. 9 B) . No further enhancement of this response was seen when platelets were added to the incubation (data not shown). SC-49992 modestly inhibited this response (-25%), whereas anti-f33 antibody had little effect (Fig. 9 B) . Discussion PMN-PLT interactions appear to play a critical role in the development of the acute inflammatory response and the resultant tissue damage and dysfunction (8, 9) . In our previous study and this current work, we have specifically corroborated this hypothesis within the context of immune complex-mediated glomerulonephritis. As we have observed, PLTs and PMNs colocalize to the glomerulus in the acute phase of NTN and become coordinately activated, resulting in glomerular dysfunction and a marked change in glomerular eicosanoid production (6) . The intent of the current work was to begin to delineate the molecular mechanisms which potentially mediate both the localization of these cells to the glomerulus and their activation in situ. This study would suggest that Fg plays an important role in both of these processes in that defibrination substantially attenuated the acute glomerular damage in NTN (as manifested by proteinuria) and significantly, though less substantially, decreased the accompanying influx of PMNs and PLTs into glomeruli. These results corroborate and expand on earlier work which showed that defibrination or induction of fibrinolysis could ameliorate immune complex-mediated glomerulonephritis both histologically and functionally although this effect was not invariable (10, 11 Fg (23, 24) . In light of the marked increase in glomerular lipid mediator production in the context of NTN (28) (29) (30) NTN. Of relevance to this comment, we observed that PLT-PMN aggregation in vitro was not invariably inhibited by Fg receptor blockade even though the respiratory burst was. Based on the available data, we would surmise that P-selectin/GMP-140 might be important to this process (33, 34) , though we have not been able to substantiate this conclusion using the anti-P selectin monoclonal antibody, PB 1.3 (kindly provided by J. Paulson, Cytel, San Diego, CA) (references 35 and 36, and Wu, X., and J. B. Lefkowith, unpublished data). However, it is possible that other molecules, such as complement components (i.e., C3b and C3bi), might serve to promote PLT-PMN adhesion, bypassing P-selectin (8, 9) . Understanding the mechanisms by which PLTs adhere to PMNs as they emigrate from the vasculature into the mesangium will require further investigation.
Although the mechanisms of concern for the current study deal with events which occur early in the inflammatory cascade, acute events clearly have important ramifications for chronic outcomes. Within the context of NTN, studies have shown that the magnitude of the acute insult to the glomerulus, if sufficiently severe, can result in glomerulosclerosis (37 PLTs contain a panoply of mediators which may contribute to perpetuation of the inflammatory response and contribute to the process of glomerulosclerosis such as PDGF, FGF, TNFa, PF4, and TGF3 (37) (38) (39) (40) . Thus, developing an understanding of the molecular mechanisms operative early on may provide insights into strategies which may be useful to prevent the long-term adverse outcome of glomerular scarring.
In conclusion, Fg appears to play a critical role in the coactivation of PLTs and PMNs within the glomerulus in acute NTN.
This activation is most likely mediated via asIb3A, the expression of which is markedly increased in glomeruli after disease induction. This altered expression appears due to the influx of PLTs in a PMN-dependent fashion which in part is mediated by Fg, but which clearly is dependent to a large degree on other molecular interactions which remain to be determined. Developing an understanding of these acute events may help in the development of strategies not only to ameliorate acute glomerular injury, but also to prevent glomerular scarring which may result from the initial insult.
